Latest Breaking News On - Ligand conjugate - Page 1 : comparemela.com

Paris, France, September 28, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces that CEO Rodolphe Clerval will be presenting to investors and peers at the following Investor and Industry conferences: Chardan’s 7th Annual Genetic Medicines Conference – October 2-3 New York City, NY, USAPresenting on October 2 at 11:30 EDT Cell & Gene Meeting on the Mesa – October 10-12 Carlsbad,

United statesFrance generalNew yorkNoord hollandBruxelles capitaleFranche comtérUnited kingdomCity ofG le meurInternational symposium on retinal degenerationUnilateral subretinal administrationEuropean society of retina specialists congressEuropean society of geneCoave therapeuticsCentral nervous systemAnnual genetic medicines conference